Aleksandra Lisowska

Aleksandra Lisowska

Auto-generated profile, based on publicly available information

Aleksandra Lisowska

Municipal Hospital in Siemianowice Śląskie, Siemianowice Śląskie, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
DSDariusz Szołtys
Dariusz Szołtys
KOKatarzyna Oberska
Katarzyna Oberska
SOSandra Olewińska
Sandra Olewińska
ALAleksandra Lisowska
Aleksandra Lisowska
HGHanna Grygorcewicz
Hanna Grygorcewicz
YPYelyzaveta Petrenko
Yelyzaveta Petrenko
Anabolic androgenic steroids (AASs) are synthetic derivatives of testosterone primarily indicated for the treatment of androgenic deficiency states. Non-clinical use of these agents has increased in recent years, particularly among athletes and individuals seeking rapid muscle hypertrophy and enhanced physical performance. Supraphysiological, off-label dosing is associated with significant systemic adverse effects. Elevated steroid levels disrupt endocrine homeostasis by suppressing the hypothalamic-pituitary-gonadal (HPG) axis. Furthermore, AAS misuse has been linked to dyslipidemia, activation of the renin-angiotensin-aldosterone system (RAAS), vascular remodeling, oxidative stress, and left ventricular hypertrophy. These mechanisms collectively add to structural remodeling of the myocardium and blood vessels, thereby increasing the risk of cardiovascular disease (CVD). Emerging evidence also indicates a higher prevalence of cardiomyopathy, arrhythmias, and premature atherosclerosis among chronic AAS users. Recent studies have associated AAS misuse with left ventricular dilation, reduced ejection fraction, and mitral regurgitation. This narrative review compiles current human-based research on the cardiovascular consequences of anabolic androgenic steroids misuse, explains the pathophysiology of CVD in this population, and highlights recommended clinical evaluations. A comprehensive literature search was executed using PubMed, Scopus, and Web of Science, focusing on original clinical cardiovascular imaging and translational studies published between 2000 and 2025.

6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MNMaria Nowakowska
Maria Nowakowska
OJOliwia Jerzyńska
Oliwia Jerzyńska
MKMiszela Kałachurska
Miszela Kałachurska
MRMartyna Rożek
Martyna Rożek
AKAleksandra Kowalewska-Kurek
Aleksandra Kowalewska-Kurek
CGConstancia Esther Guy
Constancia Esther Guy
The aim of this review is to summarize the literature on daytime naps and their duration in relation to stroke risk, with particular emphasis on physiological mechanisms, demographic factors, and lifestyle. Analysis has shown that short naps of up to 30 minutes improve cognitive functions, blood pressure regulation, and stress hormone levels, and thus may have not only a neutral but also a beneficial effect on the human body. In contrast, long naps lasting 60–90 minutes or repeated multiple times during the day appear to significantly increase the risk of stroke, especially in older individuals with comorbidities such as diabetes, obesity, or hypertension. The mechanisms linking naps to stroke risk include changes in the autonomic nervous system, blood pressure, inflammatory status, and blood–brain barrier integrity. The authors emphasize that both nighttime sleep and daytime naps can be monitored for duration and quality using modern, widely available devices, such as wrist-worn trackers or mattress-embedded sensors, allowing objective assessment of sleep patterns and early identification of stroke risk factors. Further research is needed to develop systems for early detection of abnormal sleep and nap patterns, which could serve as a basis for implementing personalized stroke prevention strategies.

6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
BNBartosz Nowak
Bartosz Nowak
MKMiszela Kałachurska
Miszela Kałachurska
MRMartyna Rożek
Martyna Rożek
MNMaria Nowakowska
Maria Nowakowska
AKAleksandra Kowalewska-Kurek
Aleksandra Kowalewska-Kurek
CGConstancia Esther Guy
Constancia Esther Guy
Background: Colorectal cancer (CRC) remains one of the leading causes of cancer-related morbidity and mortality worldwide. Besides tumor-intrinsic factors, CRC risk and progression are strongly influenced by metabolic dysfunction - including obesity, insulin resistance, and T2DM. These implications emphasize the need for therapeutic strategies that address both tumor biology and the metabolic context. Objectives: This review examines the emerging role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in colorectal cancer biology, synthesizing mechanistic, preclinical, and human evidence to evaluate their potential relevance beyond well-known glycemic control. Methods: We integrate experimental studies, animal models, and epidemiologic and clinical data to evaluate the effects of GLP-1RAs on colorectal cancer–related pathways, tumor growth and progression, and resulting clinical outcomes, with special attention given to metabolic and signaling mechanisms. Key Findings: Preclinical evidence suggests that GLP-1RAs may modulate pathways involved in cancer cell proliferation, survival, metabolism, angiogenesis, and invasion, including PI3K/Akt/mTOR, ERK, and hypoxia-associated signaling. In vivo models showcase inhibitory effects on tumor growth and metastatic potential, heightened in metabolically dysregulated settings. Human observational studies report heterogeneous but generally neutral to protective associations between GLP-1RA exposure and CRC risk, while randomized trials have primarily addressed cardiometabolic outcomes rather than being tumor-focused. Conclusions: Collectively, current evidence supports a biologically plausible role for GLP-1 receptor signaling in colorectal cancer growth and progression. Definitive clinical data are lacking, but evidence regarding GLP-1RAs justifies further investigation into their potential relevance.

24 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MAMichalina Adamczyk
Michalina Adamczyk
ALAleksandra Lisowska
Aleksandra Lisowska
PSPola Sitek
Pola Sitek
DSDariusz Szołtys
Dariusz Szołtys
KZKarolina Zygoń-Komendarczyk
Karolina Zygoń-Komendarczyk
YPYelyzaveta Petrenko
Yelyzaveta Petrenko
Superior labrum anterior to posterior (SLAP) type II lesions represent a clinically significant source of shoulder pain and dysfunction, particularly in young athletes and individuals engaged in repetitive overhead activities. Detachment of the superior labrum and biceps anchor disrupts glenohumeral biomechanics, potentially leading to instability, mechanical symptoms and impaired athletic performance. Although arthroscopic repair remains the standard surgical approach, optimal management strategies continue to evolve in response to variable return-to-sport rates and procedure-related complications observed with traditional techniques. Contemporary surgical concepts emphasize anatomic restoration of the labral-biceps complex while minimizing implant-related morbidity. Innovations such as anatomic double-pulley constructs aim to distribute fixation forces more evenly and reduce peel-back stress during overhead motion. Knotless anchor systems and low-profile suture-tape constructs have been developed to eliminate intra-articular knots, decrease chondral irritation and facilitate smoother rehabilitation. In parallel, single-portal approaches seek to reduce soft-tissue disruption without compromising biomechanical stability. For selected patients particularly those with degenerative labral tissue or advanced age, biceps-based alternatives such as tenodesis provide a viable strategy with comparable functional outcomes and potentially earlier pain relief. Early and mid-term results of these contemporary techniques demonstrate meaningful improvements in pain, shoulder function and patient satisfaction. Nevertheless, postoperative stiffness, persistent discomfort and incomplete return to high-demand activity remain clinically relevant challenges. Careful patient selection, meticulous surgical execution and individualized rehabilitation protocols are essential for optimizing outcomes. Further long-term, high-quality studies are required to refine treatment algorithms and establish durable, evidence-based recommendations.

17 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KZKarolina Zygoń-Komendarczyk
Karolina Zygoń-Komendarczyk
KOKatarzyna Oberska
Katarzyna Oberska
SOSandra Olewińska
Sandra Olewińska
PSPola Sitek
Pola Sitek
DSDariusz Szołtys
Dariusz Szołtys
YPYelyzaveta Petrenko
Yelyzaveta Petrenko
Platelet-rich plasma (PRP) is an autologous blood-derived biologic increasingly used in dermatology and aesthetic medicine due to its regenerative and immunomodulatory effects. By providing a concentrated source of platelets and their mediators, PRP has the potential to enhance angiogenesis, promote collagen remodeling, and facilitate tissue repair. These properties support its application in various areas, including hair loss treatment, scar revision, chronic wound management, and minimally invasive rejuvenation procedures. This narrative review aims to summarize the current human clinical evidence regarding PRP, focusing on its biological mechanisms, preparation methods, clinical outcomes, safety profile, and future directions. A structured search was performed in PubMed, Scopus, and Web of Science for English-language studies involving human subjects published from 2010 to 2025. The search prioritized randomized controlled trials, comparative studies, and recent systematic reviews or meta-analyses. The existing evidence most strongly supports the effectiveness of PRP in treating androgenetic alopecia and as a complementary treatment for device-based acne scar therapies, such as microneedling or fractional lasers. However, significant variability in preparation techniques—such as single versus double centrifugation, platelet dosage, leukocyte content, activation methods, and treatment schedules—poses challenges for comparability and reproducibility of results. Overall, PRP is generally well tolerated, with adverse effects typically being mild and temporary. For future advancements, it will be essential to establish standardized frameworks for characterizing PRP, enhance the reporting of its composition, and conduct rigorous long-term studies that utilize technology for improved outcome assessment.

26 May 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MNMaria Nowakowska
Maria Nowakowska
OJOliwia Jerzyńska
Oliwia Jerzyńska
MKMiszela Kałachurska
Miszela Kałachurska
MRMartyna RożeK
Martyna RożeK
AKAleksandra Kowalewska-Kurek
Aleksandra Kowalewska-Kurek
CGConstancia Esther Guy
Constancia Esther Guy
Diabetes is one of the most serious health problems of modern times. One of its most dangerous complications is hypoglycemia, defined in most cases as a drop in blood glucose concentration below 70 mg/dl. Recurrent hypoglycemia is associated with a significant increase in patient mortality due to both injuries and cardiovascular and neurological complications. The fear of hypoglycemia alone sometimes paralyzes patients' daily lives. Technological advances have made it possible to replace flawed traditional methods of self-monitoring of blood glucose with systems that enable continuous glucose monitoring, which significantly reduce the frequency and duration of hypoglycemia.The latest methods not only allow for round-the-clock blood glucose monitoring, but also warn the patient of the risk of hypoglycemia based on continuous assessment of blood glucose trends, automatic modification of the insulin dose by the device based on current results, and remote monitoring of the patient by a doctor. The use of modern methods brings long-term socioeconomic benefits in the form of a reduction in the number of severe hypoglycemia episodes and, consequently, hospitalizations and their complications. In addition, CGM systems increase patients' sense of security and control over their disease. However, the use of the latest technological advances also presents challenges for patients in terms of their ability to use new technologies, as well as social and economic constraints that hinder the implementation of the latest treatment methods.